trending Market Intelligence /marketintelligence/en/news-insights/trending/0ytfxjqh3pivjo9hmo-byw2 content esgSubNav
In This List

Mustang Bio names former Amgen director as chief medical officer

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Mustang Bio names former Amgen director as chief medical officer

Mustang Bio Inc., a clinical-stage biopharmaceutical company, appointed Martina Sersch as its chief medical officer.

Before joining Mustang, Sersch was an executive director at Amgen Inc.

New York-based Mustang Bio engages in acquiring, developing and commercializing novel cancer immunotherapy products based on the chimeric antigen receptor engineered T, or CAR T, cell technology.